Please complete the CAPTCHA to continue
@nanotechenergy.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jack Kavanaugh is listed as Serial entrepreneur and philanthropist whose life mission is to create a positive impact on society and the welfare of people everywhere. at Nanotech Energy, based in Los Angeles, California, United States. AeroLeads shows a work email signal at nanotechenergy.com and a matched LinkedIn profile for Jack Kavanaugh.
Jack Kavanaugh previously worked as Co-Founder, Chairman, CEO at Nanotech Energy and Chairman at Orbsen Therapeutics Limited. Jack Kavanaugh holds Specialty Degree In Ophthalmology (Residency) from Ucla - Jules Stein Eye Institute.
This section adds company-level context without repeating Jack Kavanaugh's masked contact details.
AeroLeads found 1 current-domain work email signal for Jack Kavanaugh. Compare company email patterns before reaching out.
I help transform groundbreaking research into industry-leading products and solutions with a key focus on biotechnology, medicine and advanced materials. It is my life’s mission to create a positive impact on society and the welfare of people by solving persistent challenges with unique science-based solutions — beginning with two successful lifetimes as a M&A/management consultant specialist as well as a board certified eye surgeon (M.D.) who transitioned to private equity.Many brilliant researchers produce ideas and viable solutions in research labs, but often lack the business acumen to bring them to market and scale them. My unique background has enabled me to support multiple exceptional researchers, as well as existing organizations, to identify opportunities for innovation and success as founder/co-founder, Chairman and/ CEO for more than a dozen companies — leading them through inception, R&D, strategic development, pivots, key inflection points and acquisition.
Listed skills include Start Ups, Mergers And Acquisitions, Strategy, Venture Capital, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Sunny Isles Beach, Florida, US
Nanotech Energy is on a mission to bring transformative, graphene-based, energy storage products from the research lab to the mass market, revolutionizing the way we power our world. Our very high surface area, single layer graphene material is already being used in multiple applications, including non-flammable batteries, transparent conducting.
Galway, IE
Orbsen is a clinical stage stromal cell immunotherapy company that is redefining cell therapy using proprietary GMP-compliant and scalable positive-selection purification strategies to develop ground-breaking, second generation stromal cell treatments to address some of today’s most challenging diseases. It has received approximately $55 million in.
SuperMetalix has created the hardest metal ever made and the only metal hard enough to scratch a diamond. It produces cost-efficient super-hard metallic composites which are twice as hard as carbide and less than half the weight that are far superior to today’s commonly-used hard metals.
Novonco targets multiple hard-to-treat cancers. Its three platform technologies are the result of years of investigation into the medicinal chemistry and cancer biology of various tumors. These molecularly-targeted drugs represent the next generation of cancer therapies, offering hope to patients with limited treatment options, including those with acute.
Silq, Inc. created a unique material that treats composites and does not allow bacterial or fungal growth and therefore prevents infections from multiple types of medical devices. FDA approval has already been received for urinary catheters. Dozens of additional medical devices are expected to follow. It has also been determined that the technology does.
Senior Manager of Multiverse Fund I (fully invested and taking no further investors) and Multiverse Fund II (which has just launched). Both funds are diversified investments into companies that have unique product offerings, most of which have gatekeeper type technology which could have significant beneficial impact on society and produce significant.
Fortem has developed a therapeutic that has shown great promise in animal studies in significantly improving the cognitive capabilities of dementia and Alzheimer’s. It is targeting human trials next.
VaultPharma is creating vaccines for Chlamydia, oral and cervical cancer and a therapeutic against a number of cancers, including pulmonary and brain cancers. It is targeting human trials next.
Los Angeles, California, US
Westwood Bioscience utilizes the silicasome as a therapeutic delivery device against a variety of cancers, and has demonstrated significant efficacy and safety improvement over the current liposome technology, an $8 billion revenue product.
LongLifeRx, Inc. has two neurtraceutical products available online; Coggevity targets improved cognitive performance and MyLife Therapeutics targets longevity, kidney and heart function. The analogues are targeted to improve kidney, brain and heart function, as well as slowing the aging process and will require human trials.
Black Light Surgical received a “Breakthrough Therapeutic” designation from the FDA for its technology. Black Light has developed a technology that in the surgical suite can quickly determine cancer from non-cancerous tissue with 99% specificity and 99% sensitivity. It has thus far been applied to breast, brain, and lung cancers. It is planning on.
As Dr. Kavanaugh predicted, Dr. Grubbs received the Nobel Prize for chemistry in November,2005 for the technology held by this Cal-Tech spin-out chemical company. Materia holds morethan 300 patents and multiple product applications.
Acquired: Celgene 2018 enterprise value of $10.1 billionKavanaugh successfully combined exclusive technological licensing from top healthcare andresearch institutions to place ZetaRx at the leading edge of immunotherapy (CAR-Tcell) for thetreatment of cancer. The ZetaRx IP portfolio and clinical trial strategy continued as the core of Juno Therapeutics.
Calhoun is a biotechnology firm that developed the world’s first and only light adjustableintraocular lens for cataract surgery. Dr. Kavanaugh played a very important and pivotal role inassisting Calhoun from its inception at CalTech to commercialization abroad (approved inEurope with a CE Mark and also in Mexico) and in leading the company into and.
Houston, TX, US
Acquired by Wex 2018 Dr. Kavanaugh was a Board member of PreCash. His efforts in 2001 staved off an imminent insolvency proceeding, and helped to lead a major turn-around. Two years later PreCash was rated by Inc. Magazine as one of the fastest growing companies in profits in the United States.
Dr. Kavanaugh was the founder and served as Chairman and CEO of Amerident, a health care service provider which he founded in 1996, grew organically from 1 to approximately 500 employees and sold at a significant multiple of invested capital to a public company approximately two and a half years from inception, in 1999. Amerident received over 30 community.
Dr. Kavanaugh was responsible for taking public Team Global (1986), where, as a member of the Board for several years, he helped guide and create value as the public share price rose approximately 300 X from an initial investor cost of 11 cents per share to approximately $33 per share.
Among multiple strategic consulting projects and Mergers & Acquisitions Dr. Kavanaugh led were Merck’s Mexican merger, a global mining strategy, the merger that created Cemex, and a global tuna fishing industry study and strategy development.
Quick answers generated from the profile data available on this page.
Jack Kavanaugh works for Nanotech Energy.
Jack Kavanaugh is listed as Serial entrepreneur and philanthropist whose life mission is to create a positive impact on society and the welfare of people everywhere. at Nanotech Energy.
AeroLeads has found 1 work email signal at @nanotechenergy.com for Jack Kavanaugh at Nanotech Energy.
Jack Kavanaugh is based in Los Angeles, California, United States while working with Nanotech Energy.
Jack Kavanaugh has worked for Nanotech Energy, Orbsen Therapeutics Limited, Supermetalix, Inc., Novonco Therapeutics, Inc., and Silq, Inc. (Formerly Hydrophilix).
You can use AeroLeads to view verified contact signals for Jack Kavanaugh at Nanotech Energy, including work email, phone, and LinkedIn data when available.
Jack Kavanaugh holds Specialty Degree In Ophthalmology (Residency) from Ucla - Jules Stein Eye Institute.
Jack Kavanaugh is listed with skills including Start Ups, Mergers And Acquisitions, Strategy, Venture Capital, Entrepreneurship, Business Strategy, Management, and Biotechnology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts